Metaplanet
3350
Mitsubishi Heavy Industries
7011
Nippon Telegraph & Telephone
9432
4
Sanrio
8136
5
Kioxia Holdings
285A
JP Stock MarketDetailed Quotes
4882 Perseus Proteomics
- 672
- -13-1.90%
20min DelayMarket Closed Feb 18 15:30 JST
9.91BMarket Cap-7.17P/E (Static)
705High665Low1.27MVolume677Open685Pre Close871.14MTurnover87652wk High9.22%Turnover Ratio14.74MShares29152wk Low-75.72EPS TTM9.29BFloat Cap1022Historical HighLossP/E (Static)13.82MShs Float255Historical Low-93.69EPS LYR5.84%Amplitude--Dividend TTM5.39P/B100Lot Size--Div YieldTTM
About Perseus Proteomics Company
Perseus Proteomics Inc is engaged in the research and development, manufacture, and sales of pharmaceuticals. It provides antibody based therapeutics and diagnostics drugs to cure against cancer and other diseases.
Company Profile
Symbol4882
Company NamePerseus Proteomics
Founded2001-02-01
MarketTSE Growth
Fiscal Year Ends03-31
Address4-7-6, Komaba Tokyo Park Building, Meguro-ku
Zip Code103-0015
Phone03-6264-8268
Websitewww.ppmx.com
Company Executives
- Name
- Position
- Salary
- Shinji Hagiwara
- Director, Executive Officer and Head of Business Development Dept and Research and Development
- --
- Shinichi Suzukawa
- Director, Executive Officer and Head of Administrative Dept
- --
- Takuya Yokokawa
- Representative Director, President and Executive Officer
- --
- Tatsuya Nagase
- Director
- --
- Takashi Ohno
- Director
- --
- Tadashi Horiuchi
- Independent Director
- --
- Nobuo Hanai
- Independent Director
- --
- Kinichirou Kominami
- Independent Director
- --